Cortigent presents 6-year study results for vision implant device Jan 29, 2026 07:30AM
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 Jan 29, 2026 07:30AM
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026 Jan 22, 2026 07:00AM
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results Nov 13, 2025 07:45AM
Vivani Medical withdraws Cortigent spin-off record date due to government shutdown Oct 3, 2025 08:30AM


Oct 3, 2025 08:30AM Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
Sep 17, 2025 08:30AM Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
Aug 13, 2025 04:20PM Vivani Medical secures $10M equity financing for semaglutide implant
Aug 13, 2025 04:20PM Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
May 29, 2025 08:31AM Vivani Medical (VANI) Files Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
May 29, 2025 08:30AM Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
May 13, 2025 04:30PM Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results
Mar 31, 2025 07:30AM Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 12, 2025 08:30AM Vivani Medical (VANI) to Spin Off Cortigent Neurostimulation Business
Mar 12, 2025 08:30AM Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
Nov 13, 2024 08:30AM Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
Sep 23, 2024 08:57AM Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
Aug 13, 2024 04:05PM Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
Jun 13, 2024 08:00AM Vivani Medical (VANI) Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
Jun 13, 2024 08:00AM Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
May 13, 2024 04:45PM Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
Mar 26, 2024 08:30AM Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 14, 2023 06:00AM Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
Oct 16, 2023 06:00AM Vivani Medical to Present at BIO Investor Forum
Sep 7, 2023 06:00AM Vivani Medical to Present at the Boulder Peptide Symposium
Sep 5, 2023 06:01AM Vivani Medical's (VANI) Cortigent to Present Orion Clinical Study Results
Sep 5, 2023 06:00AM Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10
Aug 14, 2023 05:45PM Vivani Medical Reports Second Quarter Financial Results and Provides Business Update